Full Press Release Details
WALTHAM, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc., (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company will participate in the following investor conferences:
Citi Annual BioPharma Conference: Fireside chat on Wednesday, September 6, 2023, at 9:40 a.m. ET
Wells Fargo Annual Healthcare Conference 2023: Fireside chat on Friday, September 8, 2023, at 9:30 a.m. ET
The live conference webcasts will be posted on the “Events and Presentations” page of the “Investors and Media” section of the company’s website. A replay of the webcasts will be available for approximately 90 days following the event.